Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,614,678
-$95,399 QoQ
Shares Held
42,182
-14.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#894
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2022CallValue
$308,009
CallShares
1,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $166,003,072 across 9 Drug Manufacturers - General names. ABBV ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
282,635 | $36,318,597 | |
| 2 | JNJ |
Johnson & Johnson
|
113,733 | $28,884,770 | |
| 3 | LLY |
ELI LILLY & Co
|
21,997 | $26,383,863 | |
| 4 | AMGN |
Amgen Inc
|
63,607 | $23,033,366 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
369,878 | $21,312,370 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
138,734 | $17,527,653 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
42,182 | $10,614,678 | |
| 8 | PFE |
Pfizer Inc
|
61,912 | $1,490,840 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,614,678 | 42,182 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,710,077 | 49,244 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,842,992 | 47,455 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,689,528 | 50,486 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,290,411 | 39,276 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,702,281 | 51,080 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,317,029 | 86,196 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,361,690 | 92,980 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,549,944 | 125,641 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,440,636 | 117,741 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,818,851 | 95,624 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,923,073 | 66,571 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,534,976 | 70,771 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,732,453 | 67,343 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,070,590 | 19,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,242,238 | 61,413 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,406,321 | 61,415 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,565,413 | 71,343 | Shares | Sole | 2022-05-12 | |
| 2022-03-31 | $308,009 | 1,900 | Call | Sole | 2022-05-12 | |
| 2021-12-31 | $8,995,840 | 66,439 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,776,824 | 62,824 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,206,707 | 63,980 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,916,062 | 54,667 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,730,274 | 53,479 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,698,330 | 122,141 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $5,465,680 | 55,670 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,113,040 | 53,984 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||